Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797857 · ClinicalTrials.gov registry record · NA
Exercise Training in Transthyretin Cardiac Amyloidosis
A NA study of Transthyretin Cardiac Amyloidosis and Amyloid Cardiomyopathy, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05797857 is a NA study of Transthyretin Cardiac Amyloidosis and Amyloid Cardiomyopathy that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 626-participant average among 4 other Transthyretin Cardiac Amyloidosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05797857, a NA study of Transthyretin Cardiac Amyloidosis and Amyloid Cardiomyopathy, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Transthyretin cardiac amyloidosis causes debilitating heart failure in older adults. The proposed research will develop a personalized exercise training program to improve functional capacity in patients on optimal treatment for transthyretin cardiac amyloidosis. This is a vital next step to improve functional capacity and quality of life of people suffering from transthyretin cardiac amyloidosis.
Conditions Studied
Interventions
- OTHER Exercise Training
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-07-10 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05797857
The ClinicalTrials.gov registry entry for NCT05797857 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 626-participant average among 4 other Transthyretin Cardiac Amyloidosis trials with a reported enrollment target (94% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Transthyretin Cardiac Amyloidosis appearing as the primary indexed condition, and to 1 intervention - of which Exercise Training is the first listed.
NCT05797857 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05797857 about?
NCT05797857 is a clinical study titled "Exercise Training in Transthyretin Cardiac Amyloidosis". Transthyretin cardiac amyloidosis causes debilitating heart failure in older adults. The proposed research will develop a personalized exercise training program to improve functional capacity in patients on optimal treatment for transthyretin cardiac amyloidosis. This is a vital next step to improve...
What is the current status of trial NCT05797857?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-07-10. Estimated completion is 2030-06-30.
What conditions does trial NCT05797857 study?
This clinical trial studies the following conditions: Transthyretin Cardiac Amyloidosis, Amyloid Cardiomyopathy.
What interventions are being tested in trial NCT05797857?
The interventions under investigation include: Exercise Training (OTHER).
Who is sponsoring clinical trial NCT05797857?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05797857 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transthyretin Cardiac Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
RECRUITING · Phase 4
-
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
RECRUITING
-
Bronx Transthyretin Amyloid Cardiomyopathy Database
ACTIVE NOT RECRUITING
-
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
COMPLETED · Early Phase 1
Explore more on PlainTrial
Transthyretin Cardiac Amyloidosis
All registered trials for this condition
Amyloid Cardiomyopathy
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.